Inhibition of 17&bgr; -Hydroxysteroid Dehydrogenase (17&bgr; -HSD) by Imidazole-Based Compounds

E-ISSN： 1875-628x|5|1|48-51

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.5, Iss.1, 2008-01, pp. : 48-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design, Synthesis and In Vitro Evaluation of 4-Androstene-3,17-dione/Adenosine Hybrid Compounds as Bisubstrate Inhibitors of Type 3 17&bgr;-Hydroxysteroid Dehydrogenase

Medicinal Chemistry, Vol. 2, Iss. 4, 2006-01 ,pp. : 329-347

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and Modulators of &bgr;- and &ggr;-Secretase

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 377-392

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis, Biochemical Evaluation and Rationalisation of a Series of 3,5- Dibromo Derivatives of 4-Hydroxyphenyl Ketone-Based Compounds as Probes of the Active Site of Type 3 of 17&bgr;-Hydroxysteroid Dehydrogenase (17&bgr;-HSD3) and the Role of Hydrogen Bonding Interaction in the Inhibition of 17&bgr;-HSD3

Letters in Drug Design & Discovery, Vol. 9, Iss. 6, 2012-07 ,pp. : 604-610

Bentham Science Publishers

Access to resources Recommend Favorite

The Saccharomyces cerevisiae GSK-3&bgr; Homologs

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1455-1465

Bentham Science Publishers

Access to resources Recommend Favorite

Type 1 11 &bgr;-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite